Clinical and in-vitro studies

• Niklas Arnberg, PhD, professor of virology, Department of clinical microbiology, Umeå University: In-vitro study: Viiral vs Corona-43 and common cold viruses. Study results show that Viiral inhibits 80-100% of the transduction.

• Norwegian University of Science and Technology: Investigation in preventive effect of sialic acid on infection of human nasal epithelial cells. Norway, ongoing.

• Clinical Investigation: A prospective, multicenter, randomized, controlled, blinded Post-Market Clinical Follow-up investigation to verify clinical efficacy, performance and safety of Viiral® Nasal Spray when used according to its intended use in a population with dry nose symptoms